DAVID L CUTLER
Medical Practice in Moorestown, NJ
License number
New Jersey 25MA05733500
Issued Date
Dec 19, 1991
Expiration Date
Jun 30, 2017
Category
Medical Examiners
Type
Medical Doctor
Address
Address
Moorestown, NJ
Personal information
See more information about DAVID L CUTLER at radaris.comName
Address
Phone
411 Highland Blvd, Gloucester Cy, NJ 08030
6 Vetter Ct, N Brunswick, NJ 08902
904 Mansfield Dr, Moorestown, NJ 08057
411 Highland Blvd, Gloucester Cy, NJ 08030
323 Sylvan Ave, Gloucester City, NJ 08030
Professional information
Dr. David L Cutler, Moorestown NJ - MD (Doctor of Medicine)
Specialties:
Endocrinology, Diabetes & Metabolism, Endocrinology & Metabolism
Address:
904 Mansfield Dr, Moorestown 08057
Certifications:
Diabetes, Metabolism & Endocrinology, 1989, Internal Medicine, 1986
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
University of Saskatchewan / College of Medicine
North York Genl Hosp
Mayo Clinic-Rochester
U Toronto
University of Saskatchewan / College of Medicine
North York Genl Hosp
Mayo Clinic-Rochester
U Toronto
Methods Of Using Temozolomide Formulation Intrathecally In The Treatment Of Cancers
US Patent:
2006012, Jun 8, 2006
Filed:
Nov 30, 2005
Appl. No.:
11/290779
Inventors:
David Cutler - Moorestown NJ, US
International Classification:
A61K 31/33
US Classification:
514183000
Abstract:
Methods are disclosed for treating cancer in a patient in need of such treating comprising intrathecally administering temozolomide in a pharmaceutical formulation in a therapeutically effective amount.
Methods Of Treating Cancer Using An Fpt Inhibitor And Antineoplastic Agents
US Patent:
2006018, Aug 17, 2006
Filed:
Apr 3, 2006
Appl. No.:
11/396892
Inventors:
David Cutler - Moorestown NJ, US
Michael Meyers - Hastings-on-Hudson NY, US
Charles Baum - Westfield NJ, US
Sara Zaknoen - Hoboken NJ, US
Michael Meyers - Hastings-on-Hudson NY, US
Charles Baum - Westfield NJ, US
Sara Zaknoen - Hoboken NJ, US
International Classification:
A61K 31/473, A61K 31/704, A61K 31/454, A61K 31/4745, A61K 31/28, A61K 33/24
US Classification:
514290000, 514449000, 514283000, 514034000, 514365000, 514323000, 424649000, 514492000
Abstract:
Disclosed is a method of treating cancer in a patient in need of such treatment comprising administering a therapeutically effective amount of an FPT inhibitor and therapeutically effective amounts of one or more antineoplastic agents. Methods of treating non small cell lung cancer, CML, AML, non-Hodgkin's lymphoma and multiple myeloma are disclosed.
Method Of Treating Cancer Using Fpt Inhibitors And Antineoplastic Agents
US Patent:
2004000, Jan 8, 2004
Filed:
Dec 3, 2002
Appl. No.:
10/308813
Inventors:
David Cutler - Moorestown NJ, US
Charles Baum - Westfield NJ, US
Sara Zaknoen - Hoboken NJ, US
Charles Baum - Westfield NJ, US
Sara Zaknoen - Hoboken NJ, US
Assignee:
Schering Corporation
International Classification:
A61K031/496, A61K031/7076, A61K031/704, A61K031/4745, A61K031/473, A61K031/454, A61K039/395, A61K031/525, A61K031/501
US Classification:
514/252030, 514/290000, 424/145100, 514/034000, 514/045000, 514/365000, 514/283000, 514/251000, 514/449000, 424/649000, 514/323000
Abstract:
Disclosed is a method of treating cancer in a patient in need of such treatment comprising administering a therapeutically effective amount of an FPT inhibitor and therapeutically effective amounts of one or more antineoplastic agents. Methods of treating non small cell lung cancer, squamous cell cancer of the head and neck, CML, AML, non-Hodgkin's lymphoma and multiple myeloma are disclosed.
Methods Of Treating Cancer Using An Fpt Inhibitor And Antineoplastic
US Patent:
2003018, Oct 2, 2003
Filed:
Nov 25, 2002
Appl. No.:
10/303259
Inventors:
David Cutler - Moorestown NJ, US
Michael Meyers - Hastings-on-Hudson NY, US
Charles Baum - Westfield NJ, US
Sara Zaknoen - Hoboken NJ, US
Michael Meyers - Hastings-on-Hudson NY, US
Charles Baum - Westfield NJ, US
Sara Zaknoen - Hoboken NJ, US
Assignee:
Schering Corporation
International Classification:
A61K031/7072, A61K031/7076, A61K031/704, A61K031/473, A61K031/4745, A61K031/427, A61K031/454, A61K039/395, A61K031/525
US Classification:
424/155100, 514/290000, 514/045000, 514/049000, 514/034000, 514/283000, 514/182000, 514/365000, 514/251000, 514/449000, 514/492000, 514/323000
Abstract:
Disclosed is a method of treating cancer in a patient in need of such treatment comprising administering a therapeutically effective amount of an FPT inhibitor and therapeutically effective amounts of one or more antineoplastic agents. Methods of treating non small cell lung cancer, CML, AML, non-Hodgkin's lymphoma and multiple myeloma are disclosed.